The role of cytosolic 5'-nucleotidase II (NT5C2) in drug resistance and relapse of acute lymphoblastic leukemia
Acute lymphoblastic leukemia (ALL) is an aggressive hematological cancer which arises from the malignant transformation of B-cell or T-cell progenitors. Despite recent pioneering improvements in intensified combination chemotherapy, 20% of pediatric and 50% of adult ALL patients present with primary...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
2016
|
| Subjects: | |
| Online Access: | https://doi.org/10.7916/D85Q4W77 |